Replies to post #8630 on Zivo Bioscience Inc (ZIVO)

[weazelboy]

10Q filed...

Opening line...bask in the glory...aaaahhhhh.........

Going Concern

The Company has incurred net losses since inception, experienced negative cash flows from operations for the three and nine months ended September 30, 2023, {i}and has an accumulated deficit of $121,673,166. The Company has historically financed its operations primarily through the issuance of common stock, warrants, and debt.

So, in summary, break even is roughly $70/share based on the 1,741,609 outstanding shares mentioned in the report. lolololol